{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:11:57Z","timestamp":1771049517633,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis that presents with painful, sterile ulcers. Drug-induced PG is a rare condition; propylthiouracil, granulocyte colony-stimulating factor, and sunitinib are drugs that have been implicated to date. This article presents a case of PG associated with sunitinib.<\/jats:p>","DOI":"10.1097\/01.asw.0000577128.03996.95","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:37:00Z","timestamp":1565710620000},"page":"427-429","source":"Crossref","is-referenced-by-count":4,"title":["Pyoderma Gangrenosum Associated with Sunitinib: A Case Report"],"prefix":"10.1097","volume":"32","author":[{"given":"Bahar","family":"Sevimli Dikicier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"1","key":"bib1-20230923","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40257-017-0308-7","article-title":"Drug-induced pyoderma gangrenosum: a review","volume":"19","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2003.00024.x","article-title":"Pyoderma gangrenosum: a review","volume":"30","year":"2003","journal-title":"J Cutan Pathol"},{"issue":"6","key":"bib3-20230923","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"bib4-20230923","first-page":"19","article-title":"Pyoderma gangrenosum\u2014a review","volume":"15","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5021\/ad.2010.22.1.48","article-title":"A case of p-ANCA-positive Propylthiouracil-Induced pyoderma gangrenosum","volume":"22","year":"2010","journal-title":"Ann Dermatol"},{"issue":"2","key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1540-9740.2006.04575.x","article-title":"Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor","volume":"5","year":"2006","journal-title":"Skinmed"},{"issue":"1","key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjd.15193","article-title":"Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum","volume":"177","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/2047-783X-16-11-491","article-title":"Sunitinib induced pyoderma gangrenosum\u2013like ulcerations","volume":"16","year":"2011","journal-title":"Eur J Med Res"},{"issue":"8","key":"bib9-20230923","first-page":"34","article-title":"A second case of sunitinib-associated pyoderma gangrenosum","volume":"3","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1200\/JCO.2010.32.6165","article-title":"Pyoderma gangrenosum with the use of sunitinib","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2133.2008.08599.x","article-title":"Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?","volume":"159","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-4632.2011.04952.x","article-title":"A case of pyoderma gangrenosum possibly associated with sunitinib treatment","volume":"52","year":"2013","journal-title":"Int J Dermatol"},{"issue":"3","key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2010.06.051","article-title":"The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies","volume":"65","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"bib14-20230923","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaad.2017.12.031","article-title":"Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients","volume":"78","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"bib15-20230923","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","year":"2004","journal-title":"Int J Dermatol"},{"issue":"3","key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment","volume":"18","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4103\/2249-4863.197300","article-title":"Pyoderma gangrenosum: a clinician\u2019s nightmare","volume":"5","year":"2016","journal-title":"J Family Med Prim Care"},{"issue":"2","key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1534734616639172","article-title":"Pyoderma gangrenosum: a report of 27 patients","volume":"15","year":"2016","journal-title":"Int J Low Extrem Wounds"},{"key":"bib19-20230923","doi-asserted-by":"crossref","first-page":"844","DOI":"10.12659\/AJCR.908995","article-title":"Improvement of ulcerations in treatment-resistant chronic scarring in a patient with pyoderma gangrenosum after improving vascular insufficiency, gently removing necrotic debris, and decreasing wound fluid","volume":"19","year":"2018","journal-title":"Am J Case Rep"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000577128.03996.95","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:25:51Z","timestamp":1695464751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000577128.03996.95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000577128.03996.95","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,13]]}}}